Interview: “We see the trend towards personalized medicine not as temporary, but permanent” 

Our CEO Benedikt von Braunmühl and COO Christiane Bardroff met with journalist Georg Kääb from transkript magazine to talk about our work at Rentschler Biopharma, the benefits of partnerships and the future of the ever-evolving biopharmaceutical industry.  

In this interview, also find out what it means to develop and manufacture “difficult to make” therapeutics for serious and rare diseases and how we are customizing our services, across our sites, to our clients’ specific needs. 

You can read the interview here (German language).